Press Releases Latest Dec 18, 2024 Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment Press Releases Year None202420232022202120202019201820172016201520142013 Jun 21, 2021 Theratechnologies Announces New Preclinical Findings for Its Lead Investigational Peptide-Drug Conjugate TH1902 for the Potential Treatment of Metastatic Cancers Jun 10, 2021 Theratechnologies to Host Key Opinion Leader Event to Discuss its SORT1+ Technology™ for the Treatment of All Sortilin-Expressing Cancers May 31, 2021 Theratechnologies Hires Vice President, Human Resources May 20, 2021 Theratechnologies Announces Results From Two Posters Presented at ACTHIV 2021 Annual Meeting Highlighting Positive Patient Experience With Trogarzo® May 18, 2021 Theratechnologies to Participate in Virtual Fireside Chat With Canaccord Genuity on May 20, 2021 May 13, 2021 Announcements in Conjunction With Theratechnologies Annual Meeting Apr 14, 2021 Theratechnologies Reports First Quarter 2021 Financial Results and Recent Business Highlights Apr 12, 2021 Theratechnologies to Present at the Bloom Burton & Co. Healthcare Investor Conference Apr 01, 2021 Theratechnologies to Announce Financial Results for Its First Quarter Fiscal 2021 Apr 10, 2021 Theratechnologies Presents New In Vivo Pre-Clinical Data at AACR Demonstrating Significant Anti-Tumor Activity of TH1902 in All Studied Cancer Types First page « Previous page ‹ … Page 10 Page 11 Page 12 Page 13 Current page 14 Page 15 Page 16 Page 17 Page 18 … Next page › Last page » Displaying 131 - 140 of 379
Dec 18, 2024 Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment
Jun 21, 2021 Theratechnologies Announces New Preclinical Findings for Its Lead Investigational Peptide-Drug Conjugate TH1902 for the Potential Treatment of Metastatic Cancers
Jun 10, 2021 Theratechnologies to Host Key Opinion Leader Event to Discuss its SORT1+ Technology™ for the Treatment of All Sortilin-Expressing Cancers
May 20, 2021 Theratechnologies Announces Results From Two Posters Presented at ACTHIV 2021 Annual Meeting Highlighting Positive Patient Experience With Trogarzo®
May 18, 2021 Theratechnologies to Participate in Virtual Fireside Chat With Canaccord Genuity on May 20, 2021
Apr 14, 2021 Theratechnologies Reports First Quarter 2021 Financial Results and Recent Business Highlights
Apr 10, 2021 Theratechnologies Presents New In Vivo Pre-Clinical Data at AACR Demonstrating Significant Anti-Tumor Activity of TH1902 in All Studied Cancer Types
